Bulkamid is a homogenous hydrophilic hydrogel used in the treatment of female stress urinary incontinence.

Bulkamid was granted CE approval in 2003 for use in the treatment of female urinary incontinence. More than 70,000 people have been treated to date, in over 25 countries, with a procedure that is performed under endoscopic control using the Bulkamid Urethral Bulking System.  The efficacy and safety of Bulkamid have been documented in a number of international clinical studies involving more than 3,000 patients.

Aquamid is a non-absorbable hydrogel used for soft tissue augmentation for reconstructive purposes

Aquamid does this by restoring lost volume or by adding extra volume where desired. As it does not degrade over time, the results remain for years. The efficacy and safety of Aquamid have been documented in a number of international clinical studies involving more than 5,000 patients. Over 500,000 people have been treated with Aquamid since its launch.

Aquamid Reconstruction is a non-absorbable hydrogel for soft tissue augmentation.

Aquamid Reconstruction is a non-absorbable high viscoelastic hydrogel for soft tissue augmentation where the areas to be treated require more volume or higher elasticity to provide additional volume. Aquamid Reconstruction has been successfully used in patients with facial lipoatrophy, amongst others, and its safety and efficacy data show excellent results over a period of more than 10 years.